{"id":132897,"date":"2021-12-22T22:23:02","date_gmt":"2021-12-23T06:23:02","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2021\/12\/first-ai-designed-drug-candidate-to-reach-human-trials"},"modified":"2021-12-22T22:23:02","modified_gmt":"2021-12-23T06:23:02","slug":"first-ai-designed-drug-candidate-to-reach-human-trials","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2021\/12\/first-ai-designed-drug-candidate-to-reach-human-trials","title":{"rendered":"First AI-Designed Drug Candidate To Reach Human Trials"},"content":{"rendered":"<p style=\"padding-right: 20px\"><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/first-ai-designed-drug-candidate-to-reach-human-trials.jpg\"><\/a><\/p>\n<p>Artificial intelligence (AI) backed drug discovery company Insilico Medicine announced last week that it was dosing the first healthy volunteer in a microdose trial of ISM 001\u2013005. Designed with the help of AI, the drug is a small-molecule inhibitor of a biological target that was discovered by Pharma. AI. The trial is being conducted in Australia.<\/p>\n<p>The <a href=\"https:\/\/analyticsindiamag.com\/why-did-alphabet-launch-a-separate-company-for-drug-discovery\/\">AI-designed drug<\/a> will be used to treat chronic lung disease idiopathic pulmonary fibrosis, or IPF usually leads to progressive and irreversible lung-function decline and affects 20 people out of over 100,000 globally.<\/p>\n<p>Chief Scientific Officer of Insilico, Freng Ren, said in a press release that this drug discovery and trial marks a significant milestone in the AI-drug discovery space. This is because the said candidate is the first-ever <a href=\"https:\/\/analyticsindiamag.com\/pytorch-releases-drug-discovery-platform-torchdrug\/\">AI-discovered novel molecule<\/a> based on an AI-discovered target.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Artificial intelligence (AI) backed drug discovery company Insilico Medicine announced last week that it was dosing the first healthy volunteer in a microdose trial of ISM 001\u2013005. Designed with the help of AI, the drug is a small-molecule inhibitor of a biological target that was discovered by Pharma. AI. The trial is being conducted in [\u2026]<\/p>\n","protected":false},"author":556,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,6],"tags":[],"class_list":["post-132897","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-robotics-ai"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/132897","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/556"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=132897"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/132897\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=132897"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=132897"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=132897"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}